Despite the sixteen-and-a-half-month wait for these rules, experts have criticised the rules for being vague and lacking clarity
Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty products and a segregated OTC business to emerge as the fourth largest pharma player in the country
Despite the increased uptake and social acceptance in metros, challenges remain in smaller cities and towns
The country head of Shiseido India on why global luxury beauty brand Nars Cosmetics is betting on the country to drive growth in the next decade
Deal values have touched $36.14 billion from $25.24 billion in 2023—marking a 43.2 percent increase; volumes too saw a 24.4 percent increase in 2024. Manufacturing saw 18 deals, followed by pharma and health care with 15 deals
Commoditised segments, value-for-money products, and a 30x jump in revenue in five years... Aditya Pittie has churned out a battery of fascinating consumer brands from the shelves of supermarkets. Can the 'diya' to 'broom' man now scale up his distinctive play beyond the modern trade?
AI capabilities are rapidly evolving, and no CEO today doubts the potential, but rather is asking what's the best way forward, says Christopher Young, executive VP at Microsoft
The legacy brand of vacuum cleaners and water purifiers has undergone a transformation that has brought along a company-wide shake-up, new-age products, and much-needed growth
Under the former State Bank of India chairperson's leadership, the tech giant has grown into a Rs9,116 crore-company in India. With the launch of a public sector division, the 'Made in India' Digital Lending solution and AI-driven Agentforce, the country is one of the fastest growing operating units for it globally
The central bank will have to focus on RRR—rates, rupee and (proactive) regulation. While inflationary concerns will likely ease in the coming quarters, sluggish growth and consumption demand are stubborn problems which need to be watched
How much of an impact will the indictments by US prosecutors have on Gautam Adani's growth ambitions?